In vivo 1H magnetic resonance spectroscopic measurement of brain glycine levels in nonketotic hyperglycinemia

被引:18
作者
Gabis, L
Parton, P
Roche, P
Lenn, N
Tudorica, A
Huang, W [1 ]
机构
[1] SUNY Stony Brook, Dept Radiol, Stony Brook, NY 11794 USA
[2] SUNY Stony Brook, Dept Neurol, Stony Brook, NY 11794 USA
[3] SUNY Stony Brook, Dept Pediat, Stony Brook, NY 11794 USA
关键词
magnetic resonance spectroscopy; nonketotic hyperglycinemia; glycine; glutamate/glutamine;
D O I
10.1111/j.1552-6569.2001.tb00036.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Nonketotic hyperglycinemia (NKH) is an autosomal recessive disorder of glycine metabolism. Defective glycine cleavage causes elevated concentrations of glycine in plasma, urine, and cerebrospinal fluid. A longitudinal study using magnetic resonance imaging (MRI) and single-voxel H-1 magnetic resonance spectroscopy (MRS) was performed on an infant with the typical clinical picture of NKH. He was examined twice during the course of treatment with sodium benzoate and dextromethorphan. At the age of 10 months, MRI showed normal brain structure, while MRS detected a prominent glycine peak in the brain. Repeat MRS at the age of 13 months showed a small increase in glycine peak and a prominent glutamate/glutamine peak not previously detected. The MRS measurements were consistent with the slight increase in blood glycine level and the elevation in glutamine level, indicating that H-1 MRS can be a valuable tool in the diagnosis and monitoring of treatment effects in patients with NKH.
引用
收藏
页码:209 / 211
页数:3
相关论文
共 12 条
[1]   Prognostic clues and outcome of early treatment of nonketotic hyperglycinemia [J].
Boneh, A ;
Degani, Y ;
Harari, M .
PEDIATRIC NEUROLOGY, 1996, 15 (02) :137-141
[2]   Effects of intravenous anesthetic agents on glutamate release -: A role for GABAA receptor-mediated inhibition [J].
Buggy, DJ ;
Nicol, B ;
Rowbotham, DJ ;
Lambert, DG .
ANESTHESIOLOGY, 2000, 92 (04) :1067-1073
[3]   Long-term use of high-dose benzoate and dextromethorphan for the treatment of nonketotic hyperglycinemia [J].
Hamosh, A ;
Maher, JF ;
Bellus, GA ;
Rasmussen, SA ;
Johnston, MV .
JOURNAL OF PEDIATRICS, 1998, 132 (04) :709-713
[4]   DEXTROMETHORPHAN AND HIGH-DOSE BENZOATE THERAPY FOR NONKETOTIC HYPERGLYCINEMIA IN AN INFANT [J].
HAMOSH, A ;
MCDONALD, JW ;
VALLE, D ;
FRANCOMANO, CA ;
NIEDERMEYER, E ;
JOHNSTON, MV .
JOURNAL OF PEDIATRICS, 1992, 121 (01) :131-135
[5]   NONKETOTIC HYPERGLYCINEMIA - ANALYSES OF GLYCINE CLEAVAGE SYSTEM IN TYPICAL AND ATYPICAL CASES [J].
HAYASAKA, K ;
TADA, K ;
FUEKI, N ;
NAKAMURA, Y ;
NYHAN, WL ;
SCHMIDT, K ;
PACKMAN, S ;
SEASHORE, MR ;
HAAN, E ;
DANKS, DM ;
SCHUTGENS, RBH .
JOURNAL OF PEDIATRICS, 1987, 110 (06) :873-877
[6]  
KUGEL H, 1992, P 11 SOC MAGN RES ME, V2, P2012
[7]  
McIntosh Tracy K., 1997, Emergency Medicine Clinics of North America, V15, P527, DOI 10.1016/S0733-8627(05)70316-3
[8]  
Ross BD, 1996, NMR BIOMED, V9, P279, DOI 10.1002/(SICI)1099-1492(199610)9:7<279::AID-NBM435>3.0.CO
[9]  
2-V
[10]   BENZOATE THERAPY AND CARNITINE DEFICIENCY IN NONKETOTIC HYPERGLYCINEMIA [J].
VANHOVE, JLK ;
KISHNANI, P ;
MUENZER, J ;
WENSTRUP, RJ ;
SUMMAR, ML ;
BRUMMOND, MR ;
LACHIEWICZ, AM ;
MILLINGTON, DS ;
KAHLER, SG .
AMERICAN JOURNAL OF MEDICAL GENETICS, 1995, 59 (04) :444-453